USA Compression Partners LP (USAC) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of USA Compression Partners LP stock $22.86, price $24.97, that is 8.4% below the price, quality 44 out of 100. Rating: fairly valued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range $8.98 – $29.70 · fair‑value band $14.79 – $38.63 · the $24.97 price screens above the $22.86 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 5, 2026.
Follow USA Compression Partners LP in your weekly email
Every Wednesday you see whether USA Compression Partners LP is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
USA Compression Partners, LP provides natural gas compression services in the United States.
Show moreShow less
The company offers compression services to oil companies and independent producers, processors, gatherers, and transporters of natural gas and crude oil, as well as for infrastructure applications, including centralized natural gas gathering systems and processing facilities, and gas lift applications in crude oil wells.
It also owns and operates a fleet of equipment to offer natural gas treating services, such as carbon dioxide and hydrogen sulfide removal, as well as natural gas cooling and dehydration to natural gas producers and midstream companies.
As of December 31, 2025, the company has 3.9 million horsepower in its fleet. USA Compression Partners, LP was founded in 1998 and is headquartered in Dallas, Texas.
Stock analysis
USA Compression Partners LP (USAC) currently trades at $24.97, while our model-based Fair Value estimate is $22.86, so the stock looks roughly fairly valued today (gap 9.2%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $37.09 per share, and 8 of the 22 models we run sit above the $24.97 price.
Bear case: the Multiples group reads lowest at $7.84, and 14 of the 22 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $14.79 (bear) to $38.63 (bull), the price of $24.97 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Energy sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
USA Compression Partners LP reported revenue of $998M in FY2025 versus $633M in FY2021, a compound +12.1%/yr. Reported net income was $111M in FY2025, compounding +81.4%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.
Key figures
Market cap $3.6B Mid · P/E ratio 22.1 · P/S ratio 2.83 · EPS (TTM) $1.13 · Dividend yield 8.4% · Net margin 12.4% · Return on equity 122% · Return on assets (EBIT) 8.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 56 out of 100 (medium confidence).
What moves the price
The share trades about 16% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Energy peers we cover trades at −32% fair-value upside, at −8%, USAC screens cheaper than that median.
Fair Value models
Bear$14.79Fair Value $22.86Bull$38.63
Price $24.97 · Downside -8.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF$27.18$70.97$157.5473
Growth DCF$26.44$66.24$141.1472
5Y EBITDA Exit$8.24$25.55$47.2770
All 22 models by family
DCF Models
FCF DCF$27.18$70.97$157.5473
Owner Earnings$24.38$66.06$146.5569
5Y Revenue Exitn/a$7.59$17.0569
5Y EBITDA Exit$8.24$25.55$47.2770
5Y P/E Exit$1.15$10.27$20.3464
10Y Revenue Exit$7.92$18.69$33.8263
10Y EBITDA Exit$13.88$32.50$60.8664
10Y P/E Exit$8.99$20.75$36.7761
Earnings-Based
Graham-Dodd$5.22$28.06$38.8863
Lynch FV$7.76$11.08$14.4161
PEG = 1.0$7.76$11.08$14.4157
EPV$2.37$5.85$8.9469
Dividend Discount
Gordon GGM$17.69$38.56$64.7665
DDM Multi-Stage$17.69$31.61$40.1966
Multiples
P/E Multiple$8.06$10.75$13.4463
P/S Multiple$6.20$8.26$10.3358
EV/EBITn/a$4.41$9.9061
EV/EBITDA$1.18$7.42$13.6659
Growth DCF
Growth DCF$26.44$66.24$141.1472
Rev-Margin DCFn/a$7.94$18.8369
Economic Profit
ROIC Compounder$4.28$13.90$23.4967
Growth Earnings
Growth-Adj P/E$9.46$13.52$17.5867
The fair value above starts from this blend and is adjusted for dilution from new shares.
In the last 6 months, one officer or director bought shares worth $262,200, on Aug 21, 2026.
BuyBradford D. WhitehurstDirector2× since Feb 19, 2026: 20,000 shares, avg. $26.49$529,700Aug 21, 2026
SaleChristopher W PorterOfficer40,000 shares at $26.64$1.1MFeb 20, 2026
Plus one other filing such as a grant, option exercise or tax withholding. It is not a market purchase or sale.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.80/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+5.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.4%
Start year 2020 (pandemic). Over 10 years: +13.9% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+40.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+31.8%
Dividend (yield on the price)8.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.29.1% vs 8.3%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−70% → 32%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+11.7%
Yearly sales growth analysts expect, extended to five years.
The revenue jump in 2026 (+37.9%) comes with 20% more shares (acquisition or merger paid in stock). Per share it is about +15.4%. The comparison above is unreliable in such a year.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +7.8% a year for the price and +9.1% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (96 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Positive cash flow offers limited support in this capital-intensive compression business, yet high leverage and negative equity severely restrict any moat signals.
Main risk: The new senior claims on available cash from the Class A units risk stretching coverage ratios further in this leveraged capital-intensive operation.
USA Compression recently issued over 34 million new Class A units carrying a fixed 9.25 percent annual distribution as part of an internal reorganization. This adds a senior claim on available cash in a capital-intensive compression business where our models already see overvaluation. Does the new structure help lock in distribution stability or simply stretch coverage ratios further?
Compare USA Compression Partners LP with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas Equipment & Services · 166 stocks
Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score44 · Below median
Fair Value upside−8.4% · Below median
Profitability
Return on equity (12 months)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets4.3% · Above median
Net margin (12 months)12.4% · Top 25%
Operating margin (12 months)28.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)42.7% · Top 25%
Dividend yield (12 months)8.4% · Top 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Oil & Gas Equipment & Services median · lower = cheaper
P/E (12 months)22.1× · Pricier than median
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months)2.83× · Priciest 25%
Price / free cash flow (fiscal year)13.1× · Pricier than median
EV/EBITDA8.6× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)22· sector 23
FUTURE (revenue growth)100· sector 36
PAST (return on equity)0· sector 28
HEALTH (low debt)0· sector 92
DIVIDEND (yield)100· sector 44
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is USA Compression Partners LP (USAC) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $22.86 versus a price of $24.97, about 8% lower (fairly valued).
What is the fair value of USAC?
Our model-based fair value for USA Compression Partners LP is $22.86 (as of Nov 5, 2026), built from audited fundamentals. The current price: $24.97.
What is the quality score of USAC?
USA Compression Partners LP has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for USA Compression Partners LP (USAC)?
Our model-based price target is the fair value of $22.86 (as of Nov 5, 2026) from 22 valuation models. Cautious scenario $14.79, optimistic scenario $38.63. It is a calculation from audited fundamentals, not an analyst target.
What is the USA Compression Partners LP stock forecast for 2026?
Our models put fair value at $22.86, about 8% lower versus a price of $24.97 (fairly valued). Cautious scenario $14.79, optimistic scenario $38.63. The calculation is refreshed regularly with new filings.
What is the revenue of USA Compression Partners LP (USAC)?
USA Compression Partners LP reported trailing-twelve-month revenue of about $1.3B (latest available figure, as of Nov 5, 2026).
Does USA Compression Partners LP pay a dividend?
USA Compression Partners LP currently shows a dividend yield of 8.41% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of USA Compression Partners LP (USAC) and when is the ex-dividend date?
USA Compression Partners LP pays a dividend of $2.10 per share a year, a dividend yield of 8.4%. The last ex-dividend date was Oct 26, 2026. A dividend has been paid every year since at least 2013. The payout ratio is 164% of earnings (on adjusted earnings, reported 186%). Free cash flow covers the dividend 0.91 times. Our assessment: Payout strained. The dividend exceeds reported earnings (though reported profit is often depressed by one-off charges), and free cash flow only just covers it (or coverage is unknown). Not an emergency, but little room for error.
What growth is priced into USA Compression Partners LP (USAC)?
For today's price to be fair in a discounted-cash-flow model, USA Compression Partners LP would have to grow free cash flow by +10.3 % per year for five years (discount rate 8.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.4 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of USAC use?
Our models discount USA Compression Partners LP at 8.5 %: a base by market capitalisation (mid), damped by beta 0.27, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For USA Compression Partners LP that is +10.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.5 %) and the same formula as our fair value.
How much growth has USA Compression Partners LP (USAC) delivered so far?
Over the past 5 years revenue at USA Compression Partners LP grew +8.4 % a year. The price currently implies free-cash-flow growth of +10.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of USA Compression Partners LP (USAC) growing?
The median revenue growth in the sector is +14.1 % a year. That is the yardstick for the growth priced into USA Compression Partners LP (+10.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of USA Compression Partners LP (USAC)?
The free-cash-flow yield on the price is 7.62 %: that much free cash flow USA Compression Partners LP produces per unit of market value. When it exceeds the discount rate of our models (8.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of USA Compression Partners LP (USAC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For USA Compression Partners LP it is $22.86 per share (as of Nov 5, 2026), against a price of $24.97. It is the blended result of 22 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is USA Compression Partners LP stock overvalued or undervalued in 2026?
As of Nov 5, 2026, USAC trades above its calculated fair value: price $24.97, fair value $22.86, a gap of about −8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of USAC?
No. The price is what the market pays today ($24.97); the fair value is what the company's own numbers justify ($22.86). For USA Compression Partners LP the two are $2.11 per share apart. That gap is exactly why we show both numbers side by side.
How much is USA Compression Partners LP worth?
The market values USA Compression Partners LP at about $3.6B (market capitalisation, as of Nov 5, 2026). Per share that is $24.97; our models calculate a fair value of $22.86 per share.
What do the bullish and bearish scenarios say about USAC?
Our models span a range for USA Compression Partners LP: cautious scenario $14.79, base $22.86, optimistic $38.63 per share (as of Nov 5, 2026, price $24.97). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of USAC?
USA Compression Partners LP trades at a price-to-earnings ratio of 22.1 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $22.86 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 24.6 (reported for FY2025: 27.9). Median P/E at fiscal year-end, 8 fiscal years (2016 to 2025), reported earnings, 6 of the years ex one-offs: 37.1. Other multiples: P/S 2.8, EV/EBITDA 8.6.
How solid is the balance sheet of USA Compression Partners LP (USAC)?
Balance-sheet figures for USA Compression Partners LP (as of Nov 5, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is USAC from its 52-week high?
USA Compression Partners LP trades at $24.97, about 16% below its 52-week high of $29.70 and 17% above the low of $21.32 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $22.86 is for.
Which stocks are comparable to USA Compression Partners LP?
From the same area (Energy) we also value SLB N.V, Baker Hughes Company, Halliburton Company, Tenaris S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is USA Compression Partners LP stock attractive at the current price?
The data as of Nov 5, 2026: price $24.97, calculated fair value $22.86 (−8%), Quality Score 44/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of USAC calculated?
We run USA Compression Partners LP through 22 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $22.86 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. USA Compression Partners LP itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of USA Compression Partners LP (USAC)?
The closing price on Nov 6, 2026 was $24.97. Our model-based fair value is $22.86, about 8% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with USA Compression Partners LP right now?
The model range is unusually wide ($14.79 to $38.63). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Where does the earnings growth of USA Compression Partners LP (USAC) come from?
Earnings per share at USA Compression Partners LP grew +8.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.8 %, EBIT margin +8.3 %, tax rate −0.2 %, residual (interest, one-offs) −4.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of USA Compression Partners LP
How large is the market capitalisation of USA Compression Partners LP (USAC)?
The market capitalisation of USA Compression Partners LP is $3.6B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of USA Compression Partners LP (USAC)?
The price-to-sales ratio of USA Compression Partners LP is 2.83 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of USA Compression Partners LP (USAC)?
Earnings per share at USA Compression Partners LP are $1.13 (price ÷ EPS = P/E 22.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of USA Compression Partners LP (USAC)?
The dividend yield of USA Compression Partners LP is 8.4% (payout 164%, on adjusted earnings, reported 186%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of USA Compression Partners LP (USAC)?
The net margin of USA Compression Partners LP is 12.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of USA Compression Partners LP (USAC)?
The return on equity (ROE) of USA Compression Partners LP is 122% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of USA Compression Partners LP (USAC)?
On an EBIT basis the return on assets of USA Compression Partners LP is 8.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of USA Compression Partners LP (USAC)?
The operating margin of USA Compression Partners LP is 28.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at USA Compression Partners LP (USAC)?
Revenue at USA Compression Partners LP is growing +42.7% versus a year earlier (3y avg +12.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at USA Compression Partners LP (USAC)?
Earnings per share at USA Compression Partners LP are growing +25.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does USA Compression Partners LP (USAC) carry?
The net debt of USA Compression Partners LP is $2.5B (fiscal year 2025, ≈ 9.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch USA Compression Partners LP in the live analysis
One click puts USA Compression Partners LP on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026